Press releases by members


29 November 2018
Iproteos, IBEC and VHIR to develop an innovative therapy against solid tumors Parc Científic de Barcelona (PCB)
Iproteos, IBEC and VHIR to develop an innovative therapy against solid tumors The biotechnology company Iproteos and the Institute of Bioengineering of Catalonia (IBEC), based at the Barcelona Science Park (PCB), and the Vall d'Hebron Research Institute (VHIR) are set to develop an innovative treatment to slow down, stop and even reverse the growth of solid tumors, which represent more than 90% of cancer cases.
  View more
26 November 2018
VIVEbiotech receives the Technological Innovation SME Award granted by Expansión and Ifema VIVEbiotech
VIVEbiotech receives the Technological Innovation SME Award granted by Expansión and Ifema This past Monday, November the 19th, the winners of the SME Awards granted by Expansión and Ifema were announced. VIVEbiotech has won the Technological Innovation Award.
  View more
21 November 2018
Francesc Xavier Grau and Joan Gómez Pallarès visit the Barcelona Science Park Parc Científic de Barcelona (PCB)
Francesc Xavier Grau and Joan Gómez Pallarès visit the Barcelona Science Park Francesc Xavier Grau, secretary for University and Research of the Generalitat (Government of Catalonia), and Joan Gómez Pallarès, director general for Research of the Generalitat, both paid an institutional visit to the Barcelona Science Park, which this year celebrates its 20th anniversary as a centre for scientific, technological and entrepreneurial innovation.
  View more
21 November 2018
BACAGRO Proyect successfull completion BIORIZON BIOTECH, S.L.
BACAGRO Proyect successfull completion BACAGRO concludes with excelent results for improvement of agroicultural fertility.
Joint work of the University of Almeria, Cajamar, Biorizon Biotech and Clever under European Union's Feder Funds.
  View more
31 October 2018
Barcelona Science Park is an accredited provider for the ACCIÓ's Innovation Coupons programme Parc Científic de Barcelona (PCB)
Barcelona Science Park is an accredited provider for the ACCIÓ's Innovation Coupons programme The Barcelona Science Park (PCB) is an accredited provider for the Innovation Coupons programme, an initiative of ACCIÓ for companies with 5–100 employees that want to carry out an innovative project, be it an improvement in a production process or a new service, product or business model.
  View more
26 October 2018
Fruit Attraction BIORIZON BIOTECH, S.L.
Fruit Attraction In his first solo participation in Fruit Attraction, coinciding with the tenth anniversary of this great international exhibition, Biorizon Biotech has captured much of the interest of professionals, companies and entities very interested in the research and development of products derived from microalgae.
  View more
24 October 2018
Cebiotex awarded the Cecot Recognition of Innovation prize 2018 Parc Científic de Barcelona (PCB)
Cebiotex awarded the Cecot Recognition of Innovation prize 2018
Cebiotex awarded the Cecot Recognition of Innovation prize 2018. Joan Bertran, CEO and co-founder of the biotechnology company based at the Barcelona Science Park (Parc Científic de Barcelona, PCB), yesterday received the award at the National Theatre of Catalonia, as part of the 24th Night of the Entrepreneur, which was chaired by the president of Catalonia, Quim Torra.
  View more
24 October 2018
Workshop at CENER that will seek to promote a new industry model linked to microalgae CENER, BIO2C – Biorefinery and Bioenergy Centre
Workshop at CENER that will seek to promote a new industry model linked to microalgae Focusing on technicians of agrifood, chemical, energy, public administrations, technology and research centers as well as the general public, the workshop will present the main results obtained to date and the objectives of the CYCLALG project, on October 30 from 9:30 am at the CENER headquarters.
  View more
8 October 2018
Cybelion® receives Organic Certification PlantResponse Biotech S.L.
Cybelion® receives Organic Certification Our biostimulant Cybelion® has received organic certification. Cybelion® is an extract made from mycelial cellular membranes that stimulates plant growth, strengthens the crop, and enhances the yield and quality of the harvest.
  View more
21 September 2018
Barcelona Science Park celebrates 20 years as a scientific and business innovation centre Parc Científic de Barcelona (PCB)
Barcelona Science Park celebrates 20 years as a scientific and business innovation centre
Yesterday, Barcelona Science Park (Parc Científic de Barcelona, PCB) held the first of a number of events scheduled to commemorate its 20 years as a meeting place for universities, companies and society. Established by the University of Barcelona (UB) in 1997, was the first science park in Spain.
  View more
21 September 2018
BIOLAN reinforces its commitment to the Philippine market by participating in its National Tuna Congress BIOLAN MICROBIOSENSORES
BIOLAN reinforces its commitment to the Philippine market by participating in its National Tuna Congress On September 5, 6 and 7, took place in General Santos, Philippines, the National Tuna Congress in which BIOLAN participated accompanying collaborating companies and customers.
  View more
3 September 2018
BIOLAN has taken part in the AOAC 132nd Annual Meeting & Exposition at Toronto BIOLAN MICROBIOSENSORES
BIOLAN has taken part in the AOAC 132nd Annual Meeting & Exposition at Toronto The AOAC INTERNATIONAL, Association of Official Analytical Chemists, has celebrated its 132nd Annual Meeting & Exposition in Toronto (Canada), from 26 till 29 August, 2018, and BIOLAN, as AOAC International Affiliate member, has participated in this event presenting its own innovative analytical methods for food quality and safety.
  View more
27 August 2018
New Agriculture Project in Sierra Leone BIORIZON BIOTECH, S.L.
New Agriculture Project in Sierra Leone Spanish biotechnology company BiorizonBiotech is moving forward with the implementation of its Nueva Agricultura project, launched in September 2016 and aimed at the economic and social development of the community of Madina, in the northern district of Kambia, Sierra Leone. About 300 adults and about 70 children currently live in Madina. Everyone participates and benefits from this project.
  View more
30 July 2018
SOM Biotech initiates of Phase 2a clinical trial of SOM3355 in Huntington’s disease patients Parc Científic de Barcelona (PCB)
SOM Biotech initiates of Phase 2a clinical trial of SOM3355 in Huntington’s disease patients SOM Biotech, a clinical-stage biopharmaceutical company that discovers and develops drugs for orphan indications in the central nervous system, has initiated of Phase 2a clinical trial of its compound SOM3355 for the treatment of the chorea movements associated to Huntington’s disease. The investigational product is a repositioned drug, currently commercialized for the treatment of hypertension.
  View more
30 July 2018
OSASEN will present at the BIOSPAIN 2018 its last innovative biosensors for healthcare OSASEN SENSORES, S.L.
OSASEN will present at the BIOSPAIN 2018 its last innovative biosensors for healthcare OSASEN SENSORES belonging to the BIOLAN Group will participate actively at the BIOSPAIN 2018 Convention that will be held from September 25 to 27 in the city of Seville.
  View more
25 July 2018
Participation of BIOLAN and OSASEN at EuroScience Open Forum 2018 OSASEN SENSORES, S.L.
Participation of BIOLAN and OSASEN at EuroScience Open Forum 2018 The 8th EuroScience Open Forum (ESOF) edition has taken place in Toulouse (France), from 9 till 14 July, 2018, and the BIOLAN Group has participated in this event presenting its last technological advances.
  View more
25 July 2018
Maria Terrades, CEO of the Barcelona Science Park Parc Científic de Barcelona (PCB)
Maria Terrades, CEO of the Barcelona Science Park

The Barcelona Science Park (Parc Científic de Barcelona, PCB) Board of Trustees agreed to appoint Maria Terrades as the PCB’s General Director on 21 June. She moves into the post with the aim of consolidating the Park as one of the leading European clusters for research excellence, entrepreneurship and innovation in life sciences.
  View more
24 July 2018
medmesafe is one of the 100 finalists of the south summit medmesafe
medmesafe is one of the 100 finalists of the south summit medmesafe is the first online platform that offers genetic analysis services with video consulting.
Through the platform, anyone can know their genetic predisposition to develop certain diseases with a strong genetic component. Then, advised by a doctor, make preventive decisions that minimize the potential risk of develop diseases and improve their health.
  View more
24 July 2018
medmesafe launches a new genetic counselling service through online videoconsultation medmesafe
medmesafe launches a new genetic counselling service through online videoconsultation According to WHO, 20% of our health depends on our genes, so it is important to understand the role they play and the influence they have. In this sense, medmesafe has launched a new genetic counseling service directly available through the platform.
  View more
23 July 2018
Participation of BIOLAN and OSASEN at EuroScience Open Forum 2018 BIOLAN MICROBIOSENSORES
Participation of BIOLAN and OSASEN at EuroScience Open Forum 2018 The 8th EuroScience Open Forum (ESOF) edition has taken place in Toulouse (France), from 9 till 14 July, 2018, and the BIOLAN Group has participated in this event presenting its last technological advances.
  View more
18 July 2018
ilS, five years connecting companies with world experts in health sciences Parc Científic de Barcelona (PCB)
ilS, five years connecting companies with world experts in health sciences The consultancy firm Insights in Life Sciences (ilS), which is based at the Barcelona Science Park, is celebrating its fifth anniversary this year, with more than 100 projects under its belt, 40 clients and a network of 15,000 experts across the world.
  View more
27 June 2018
Almirall seeks new compounds to improve skin health Almirall, S.A.
Almirall seeks new compounds to improve skin health AlmirallShare new call aims at finding a use for existing advanced small molecules in the treatment of atopic dermatitis, psoriasis, actinic keratosis, acne, and related dermatological diseases
  View more
13 June 2018
BIORIZON BIOTECH, IN THE EUROPEAN RESEARCH AND APPLICATION ELITE ON MICRO-ALGAE BIORIZON BIOTECH, S.L.
BIORIZON BIOTECH, IN THE EUROPEAN RESEARCH AND APPLICATION ELITE ON MICRO-ALGAE The biotechnology-based company Biorizon Biotech from Almeria has joined as a full partner in the European Algae Biomass Association (EABA), based in Brussels, chaired by Vito Verdelho.
  View more
7 June 2018
XI Edición del Programa en “Desarrollo de Negocio y Licencias en la Industria Farmacéutica” de CESIF en Barcelona Centro de Estudios Superiores de la Industria Farmacéutica
XI Edición del Programa en “Desarrollo de Negocio y Licencias en la Industria Farmacéutica” de CESIF en Barcelona Curso de Introducción y Entrenamiento a la función de Desarrollo de Negocio y Licencias en las áreas de Éticos, Genéricos y Consumer Health.
  View more
21 May 2018
CESIF convoca la III Edición del Programa "Regulatory & Compliance: socios estratégicos en el Sector Salud" Centro de Estudios Superiores de la Industria Farmacéutica
CESIF convoca la III Edición del Programa La III Edición del Programa se realizará en la Sede de CESIF en Madrid, junto a Regulatory 3.0 y en colaboración con AEFI (Asociación Española de Farmacéuticos de la Industria).
  View more
21 May 2018
BIORIZON BIOTECH ENHANCES INVESTIGATION BIORIZON BIOTECH, S.L.
BIORIZON BIOTECH ENHANCES INVESTIGATION It is intended to optimize the obtaining procedure adjusting parameters and establishing quality controls in order to determine optimal operational conditions required to stabilize specific bacterial strain.
  View more
16 May 2018
Launching MedTeX, the accelerator for medical technology Parc Científic de Barcelona (PCB)
Launching MedTeX, the accelerator for medical technology The Barcelona Science Park, the Bosch i Gimpera Foundation and the Barcelona Entrepreneurship Institute are giving the go ahead for the MedTeX acceleration programme, a ground-breaking initiative —co-financed by ACCIÓ— to boost emerging enterprises with an innovative business project that shows a clear international commitment within the field of medical technologies and digital health.
  View more
14 May 2018
DTI Foundation: A decade promoting research and training in donation and transplant Parc Científic de Barcelona (PCB)
DTI Foundation: A decade promoting research and training in donation and transplant Yesterday, DTI Foundation celebrated its 10th anniversary at Barcelona Science Park. The Foundation —created in Barcelona in 2008— was conceived with the aim of providing consultancy, training and support to professionals in the area of organ, tissue and human cell donation and transplantation worldwide.
  View more
26 April 2018
BIOFISH 300 SULPHITE CERTIFIED AS AOAC® PTM, SECOND CERTIFICATION AOAC OBTAINED BY BIOLAN BIOLAN MICROBIOSENSORES
BIOFISH 300 SULPHITE CERTIFIED AS AOAC® PTM, SECOND CERTIFICATION AOAC OBTAINED BY BIOLAN BIOFISH 300 SUL has been certified as AOAC® Perfomance TestedSM by the AOAC Research Institute under license number 031802 for the determination of sulphites (measured as SO2) in raw and boiled shrimp.
  View more
25 April 2018
CESIF convoca la II Edición del Programa Superior en Market Access Centro de Estudios Superiores de la Industria Farmacéutica
CESIF convoca la II Edición del Programa Superior en Market Access Tras el éxito de la primera edición, el Centro de Estudios Superiores de la Industria Farmacéutica (CESIF) convoca una nueva edición del Programa Superior de Especialización en Market Access que se impartirá desde noviembre de 2018 en Madrid.
  View more
19 April 2018
GalChimia opens an R&D centre in the Barcelona Science Park Parc Científic de Barcelona (PCB)
GalChimia opens an R&D centre in the Barcelona Science Park Galician company GalChimia –a specialist in organic chemistry products and services for the pharmaceutical industry– has today opened its R&D centre in the Barcelona Science Park to step up its growth and internationalisation strategy.
  View more
4 April 2018
Vytrus finishes 1M capital round Vytrus Biotech - Phyture
Vytrus finishes 1M capital round Vytrus has succesfully finished its capital round, that started during the last trimester of 2017, obtaining new ressource, with the value of 1 million euros. This investment will allow the company to continue it's expansion strategy, including its future incorporation on a European secondary stock market.
  View more
23 March 2018
Excellent reception of the BIOFISH 300 in the presentation to the fishing sector and food safety authorities of Morocco BIOLAN MICROBIOSENSORES
Excellent reception of the BIOFISH 300 in the presentation to the fishing sector and food safety authorities of Morocco On February 8, BIOLAN, through its delegation in Morocco, organized a conference at the Kenzi Hotel in Casablanca (Morocco) to present the BIOLAN technology.
  View more
6 March 2018
Biorizon Biotech, the only at the IV International Biotechnology Symposium, held in Fez BIORIZON BIOTECH, S.L.
Biorizon Biotech, the only at the IV International Biotechnology Symposium, held in Fez The invitation of the Almeria Company was endorsed by the professor of the Engineering Department of the University of Almería and member of the Hassan II Academy of Sciences and Techniques of Morocco, the professor, and researcher El Hassan Belarbi Haftllaoui
  View more
15 February 2018
DSM to exclusively market BIOMILK 300, residual lactose analyser produced by BIOLAN, expanding availability for dairy producers worldwide BIOLAN MICROBIOSENSORES
DSM to exclusively market BIOMILK 300, residual lactose analyser produced by BIOLAN, expanding availability for dairy producers worldwide DSM, a global science-based company active in health, nutrition and materials will exclusively market BIOMILK 300.
  View more
24 January 2018
EIT Health Wild Card: €4 million in search of innovative health ideas Parc Científic de Barcelona (PCB)
EIT Health Wild Card: €4 million in search of innovative health ideas Within the framework of the Wild Card programme, EIT Health consortium –the largest European body for innovation in healthy living and active ageing– has announced €4 million in funding for disruptive initiatives that help transform European healthcare and mitigate the social and economic impact of the progressive ageing of the population.
  View more
21 January 2018
Lipopharma awarded a 6,15M€ grant by the H2020 Programme to conduct a PIIb trial with 2OHOA in patients with newly-diagnosed glioblastoma Lipopharma Therapeutics
The European Commission (EC) has awarded a 6,15M€ grant to develop the project CLINGLIO to a multinational consortium lead by Lipopharma and integrated by 12 leading clinical research institutions, Universities and SMEs from Europe, Israel and the USA. The objective of CLINGLIO is the execution of “A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma”. The duration of the CLINGLIO project is 36 months and the starting date is 1st of December, 2017
  View more
16 January 2018
CESIF convoca la V Ed. del Programa en Project Management en Investigación Clínica Centro de Estudios Superiores de la Industria Farmacéutica
CESIF convoca la V Ed. del Programa en Project Management en Investigación Clínica Avalada por anteriores ediciones, esta formación pionera y única está orientada a la obtención de la Certificación en PMP® (Project Management Professional) adaptado a la Investigación Clínica y alineado con el PMBOK® del PMI® 6 edición (septiembre de 2017).
  View more
16 January 2018
CESIF convoca la X Ed. del Programa en Desarrollo de Negocio y Licencias en la Industria Farmacéutica en Madrid Centro de Estudios Superiores de la Industria Farmacéutica
CESIF convoca la X Ed. del Programa en Desarrollo de Negocio y Licencias en la Industria Farmacéutica en Madrid Dirigido a profesionales de la Industria Farmacéutica y Biotecnológica, así como a Jefes de Unidades de Negocio, Country Managers y Directores de compañías de reciente creación, que buscan un aplicación inmediata de las herramientas utilizadas en Desarrollo de Negocio.
  View more
15 January 2018
Mind the Byte acquires Intelligent Pharma Parc Científic de Barcelona (PCB)
Mind the Byte acquires Intelligent Pharma Mind the Byte a pioneer in the development of technologies based on artificial intelligence, cloud and big data for computational drug design, has acquired 100% of Intelligent Pharma, one of the leaders in Spain in chemoinformatics services for the pharmaceutical and biotechnology industry.
  View more
9 January 2018
Biosearch S.A. signs a license agreement with Nestlé for its “Lactobacillus fermentum LC40 ®” strain. Biosearch S.A.
Biosearch S.A. signs a license agreement with Nestlé for its “Lactobacillus fermentum LC40 ®” strain. Biosearch, S.A., a leading biotechnical company in the world of healthy ingredients, has announced the signing of a license and supply agreement with Nestec S.A., a company of the Nestlé group, for the worldwide marketing of “Hereditum® Lactobacillus fermentum LC40®” in a food supplement aimed at breastfeeding women for the purpose of maintaining healthy lactation.
  View more
Developed by Web4Bio